Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caprylate-dependent auto-anti-e.

V E Dube, C Zoes, P Adesman

    Vox Sanguinis
    |December 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    A novel autoantibody targeting the red blood cell e antigen, dependent on caprylate, was identified. This IgM antibody is inactivated by 2-mercaptoethanol, suggesting potential conformational changes in Rh antigens.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recall memory for visually presented chess positions.

    Memory & cognition·2011
    Same author

    Suppression of lymphocyte function with breast carcinoma I-active glycopeptides.

    Immunological investigations·1988
    Same author

    An immunosorbent assay for blood group I antigens in breast carcinoma.

    Clinical immunology and immunopathology·1987
    Same author

    The structural relationship of blood group-related oligosaccharides in human carcinoma to biological function: a perspective.

    Cancer metastasis reviews·1987
    Same author

    Characterization of the oligosaccharide alditols from ovarian cyst mucin glycoproteins of blood group A using high pressure liquid chromatography (HPLC) and high field 1H NMR spectroscopy.

    The Journal of biological chemistry·1986
    Same author

    Specificity of the monoclonal anti-I antibody (Hy).

    Molecular immunology·1986
    Same journal

    Barriers and enablers to non-remunerated plasma donation: A meta-synthesis of the qualitative literature using the theoretical domains framework.

    Vox sanguinis·2026
    Same journal

    Haemolytic disease of the foetus and newborn due to anti-M: A systematic review.

    Vox sanguinis·2026
    Same journal

    In vitro evaluation of apheresis platelet and plasma products collected and stored in non-DEHP disposable sets.

    Vox sanguinis·2026
    Same journal

    Survey of national and regional rare donor programmes regarding Immunoglobulin A deficiency.

    Vox sanguinis·2026
    Same journal

    Fibrinogen recovery in cryoprecipitate prepared from thawed plasma stored for 5 days post-thaw.

    Vox sanguinis·2026
    Same journal

    Abstracts of the 39th International Congress of the ISBT, Kuala Lumpur, Malaysia, 20-24 June 2026.

    Vox sanguinis·2026
    See all related articles

    Area of Science:

    • Immunology
    • Hematology
    • Serology

    Background:

    • Autoantibodies can cause various red blood cell disorders.
    • Specificities of autoantibodies are crucial for diagnosis and understanding pathogenesis.
    • The Rh blood group system is clinically significant in transfusion medicine.

    Observation:

    • A unique autoantibody was detected with reactivity dependent on caprylate.
    • This autoantibody specifically targets the e antigen on red blood cells.
    • The antibody's reactivity was abolished by 2-mercaptoethanol treatment.

    Findings:

    • The autoantibody was characterized as likely belonging to the immunoglobulin M (IgM) class.
    • No cross-reactivity was observed with albumin.
    • Caprylate appears to induce or stabilize a conformational change in the red cell Rh antigen, enabling antibody binding.

    Related Experiment Videos

    Implications:

    • This discovery expands the known specificities of red blood cell autoantibodies.
    • Understanding caprylate-dependent reactivity may reveal new mechanisms in immune red cell destruction.
    • Further research could lead to improved diagnostic tools for rare antibody specificities.